Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndrome (MDS)

Explore clinical trials studying Myelodysplastic Syndrome (MDS). Study availability and eligibility vary by location and protocol.

57 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndrome (MDS) trial results

Completed

Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant

NCT00796068

Conditions
Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, +25 more
Locations
  • University of Colorado Hospital Aurora, Colorado, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

AML-MDS Novel Prognostic Tests Clinical Study

NCT01685619

Conditions
Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Vancouver General Hospital Vancouver, British Columbia, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
  • Queen Elizabeth II Health Sciences Centre Halifax, Nova Scotia, Canada
View Trial Details
Completed

Phase I Study of S64315 Administred Intravenously in Patients With Acute Myeloid Leukaemia or Myelodysplastic Syndrome

NCT02979366

Conditions
Acute Myeloid Leukaemia (AML), Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • Patient Care Location: Smilow Cancer Hospital at Yale New Haven, Connecticut, United States
  • The University of Texas MD Anderson Cancer Center, Department of Leukemia, Division of Cancer Medicine Houston, Texas, United States
  • The Alfred Hospital Department of Haematology Melbourne, Australia
  • Royal Melbourne Hospital, Department of Clinical Haematology and BMT Service Melbourne, Australia
View Trial Details
Completed

A Phase 1 Study of AMV564 in Patients With Intermediate or High-Risk Myelodysplastic Syndromes

NCT03516591

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Washington University, Siteman Cancer Center St Louis, Missouri, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details

Related conditions